This cluster is dominated by passive-index rebalancing (4 of 5 buyers are mega-passive), not active fundamental conviction, treat the signal as low conviction. Wait for a catalyst-linked active buyer or an actionable catalyst filing before acting.
CRVS drugs
CRVS drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Jun 11 $11.60entry
- T+1 · 5mo ago +2.84%α +2.30% · $11.93
- T+5 · 5mo ago +3.45%α +3.01% · $12.00
- T+20 · 4mo ago +39.66%α +37.76% · $16.20
- T+60 · 2mo ago +24.05%α +19.66% · $14.39
How similar events traded
Executive Summary
An institutional cluster formed in CRVS during 2025-Q3, with five institutions, including State Street, Fidelity, and Wellington, adding positions totaling $6.7M in net buying, while only Morgan Stanley trimmed its position.
Key Financial Metrics
Institutional Positions
Net institutional flow: $6.7M
▲ Buyers (5)
| Institution | Action | Change | Position Value | Value Δ |
|---|---|---|---|---|
| State Street | ADD | +51.4% | $7.4M | $4.8M |
| Fidelity | DOUBLED | +529.1% | $11.0K | $10.0K |
| Wells Fargo | ADD | +34.4% | $268.0K | $160.0K |
| UBS | ADD | +80.7% | $1.2M | $836.0K |
| Wellington Management Group | ADD | +76% | $1.3M | $919.0K |
▼ Sellers (1)
| Institution | Action | Change | Prev Value | Value Δ |
|---|---|---|---|---|
| Morgan Stanley | TRIM | -31% | $3.6M | $971.0K |
Key Facts
- 5 institutional buyers added a net $6.7M in CRVS during Q3 2025
- 4 of 5 buyers are mega-passive funds (State Street, Fidelity, Wells Fargo, UBS); only Wellington is an active asset manager
- State Street alone added $4.8M, accounting for most of the net buying
- Morgan Stanley trimmed 31% of shares but raw value increased due to share price appreciation
- Ticker has 92% analyst buy/strong-buy rating and $938M market cap
Financial Impact
Institutional buyers added $6.7M in new holdings while one seller trimmed $971K in value (though dollar amount rose due to price), for net institutional accumulation of approximately $5.7M.
Risk Factors
- 45-day 13F reporting lag, positions as of Sep 30, 2025 may have been fully unwound
- Passive-dominated buying → no active fundamental thesis to trade against
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 institutional 13F filing from SEC EDGAR.
| Document | Accession Number |
|---|---|
| INST-CLUSTER Data (Synthetic) | inst-cluster-CRVS-2025-Q3 |
Track record
15 reports on CRVS
1 of 3 bullish or bearish reports moved the stock their way by T+60. Best: +2.61% at T+1 after the Mar 12, 2026 report. 2 of 3 went positive at some point.
Filters
- Nov 13, 20263d ago Insider Buy Neutral 3/10 Entry $11.20 settles Feb 12
- Nov 10, 20266d ago SC 13G Neutral 3/10 Entry $11.37 settles Feb 8
- Nov 5, 202611d ago 8-K Neutral 4/10 Entry $10.54 settles Feb 4
- Nov 5, 202611d ago Press Release Neutral 4/10 No price data
- Nov 4, 202612d ago Press Release Neutral 4/10 Entry $10.57 settles Feb 2
- Sep 30, 20266w ago Press Release Neutral 3/10 Entry $10.93 settles Dec 28
- Aug 21, 202612w ago Institutional Cluster Bullish 6/10 Entry $14.46 to $10.60 ▼ −26.69% −23.33% vs SPY
- Jul 22, 202616w ago 8-K Neutral 2/10 Entry $13.68 to $9.85 ▼ −28.00% −32.55% vs SPY
- Jun 11, 202622w ago Institutional Cluster Neutral 3/10 Viewing Entry $11.60 to $14.39 ▲ +24.05% +19.66% vs SPY
- May 14, 202626w ago 8-K Bullish 7/10 Entry $13.66 to $13.74 ▲ +0.62% −2.97% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers